Notice of Closed Meeting, 9290 [2023-02971]

Download as PDF 9290 Federal Register / Vol. 88, No. 29 / Monday, February 13, 2023 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Prevention and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. Centers for Disease Control and Prevention [FR Doc. 2023–02971 Filed 2–10–23; 8:45 am] AGENCY: khammond on DSKJM1Z7X2PROD with NOTICES Notice of Closed Meeting Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 117–286. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— RFA–PS23–002, Enhancing Telehealth Strategies to Support Retention and Adherence to Antiretroviral Therapy (ART) and RFA–PS23–005, Expanding Rapid Initiation of Antiretroviral Therapy in Non-traditional Settings: Emergency Department. Date: May 24–25, 2023. Time: 10 a.m.–5 p.m. (EDT) Place: Teleconference, Centers for Disease Control and Prevention, Room 1077, 8 Corporate Blvd., Atlanta, GA 30329. Agenda: To review and evaluate grant applications. For Further Information Contact: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8–1, Atlanta, Georgia 30329, Telephone: (404) 718– 8833, Email: GAnderson@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Health Statistics; Notice of Charter Renewal Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: ACTION: Notice of charter renewal. The Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS), announces the renewal of the charter of the Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS). SUMMARY: FOR FURTHER INFORMATION CONTACT: Rebecca Hines, M.H.S., Designated Federal Officer, Board of Scientific Counselors, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Mailstop P–08, Hyattsville, Maryland 20782; Telephone: (301) 458–4715; Email: RSHines@cdc.gov. CDC is providing notice under 5 U.S.C. 1001– 1014. This charter has been renewed for a two-year period through January 19, 2025. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. SUPPLEMENTARY INFORMATION: Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2023–02968 Filed 2–10–23; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 17:10 Feb 10, 2023 Jkt 259001 PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 CDC Moving Forward Reorganization Centers for Disease Control and Prevention, (CDC), Department of Health and Human Services (HHS). ACTION: General notice. The Centers for Disease Control and Prevention (CDC), an agency within the Department of Health and Human Services (HHS), announces a reorganization. The CDC Director is modernizing the agency’s organizational structure to better position the agency to respond to and tackle future public health threats. DATES: This reorganization was approved by the Secretary of HHS on January 24, 2023, and became effective February 8, 2023. FOR FURTHER INFORMATION CONTACT: D’Artonya Graham, Office of the Chief Operating Officer, Office of the Director, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS TW–2, Atlanta, GA 30329; Telephone 770–488–4401; Email: reorgs@cdc.gov. SUPPLEMENTARY INFORMATION: Part C (CDC) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, amended most recently at 87 FR 51670–51675, dated August 23, 2022) is amended to reflect the reorganization of CDC. Specifically, the changes are as follows: Under Part C, Section C–B, Organization and Functions, delete and/ or update functional statements for CDC in their entirety and replace with the following: I. Under Part C, Section C–B, Organization and Functions, the following organizational units are deleted in their entirety: • Office of the Associate Director for Global Health Coordination (CAE) • Deputy Director for Public Health Service and Implementation Science (CB) • Center for Global Health (CBB) • Center for Preparedness and Response (CBC) • Center for State, Tribal, Local and Territorial Support (CBD) • Office of Minority Health and Health Equity (CBE) • Deputy Director for Public Health Science and Surveillance (CP) • Office of Science (CPP) • Office of Laboratory Science and Safety (CPQ) SUMMARY: E:\FR\FM\13FEN1.SGM 13FEN1

Agencies

[Federal Register Volume 88, Number 29 (Monday, February 13, 2023)]
[Notices]
[Page 9290]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-02971]



[[Page 9290]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the 
following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as 
amended, and the Determination of the Director, Strategic Business 
Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant 
to Public Law 117-286. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--RFA-PS23-002, Enhancing 
Telehealth Strategies to Support Retention and Adherence to 
Antiretroviral Therapy (ART) and RFA-PS23-005, Expanding Rapid 
Initiation of Antiretroviral Therapy in Non-traditional Settings: 
Emergency Department.
    Date: May 24-25, 2023.
    Time: 10 a.m.-5 p.m. (EDT)
    Place: Teleconference, Centers for Disease Control and Prevention, 
Room 1077, 8 Corporate Blvd., Atlanta, GA 30329.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, National Center for HIV, Viral Hepatitis, 
STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8-1, 
Atlanta, Georgia 30329, Telephone: (404) 718-8833, Email: 
[email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-02971 Filed 2-10-23; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.